Tag Archives: access

Chemotherapy can complicate immediate breast reconstruction after mastectomy

Chemotherapy is increasingly used to treat larger operable or advanced breast cancer prior to surgery. Chemotherapy delivered via the placement of a central venous line that remains in place for the duration of treatment can result in pre-operative thromboembolic events, which can require the administration of anticoagulation agents…

Not all induced pluripotent stem cells are made equal

This means the type of cell obtained from an individual patient to make pluripotent stem cells, determines what can be best done with them. For example, to repair the lung of a patient with lung disease, it is best to start off with a lung cell to make the therapeutic stem cells to treat the disease, or a breast cell for the regeneration of tissue for breast cancer patients…

Mapping the interactome: Proteomics reveals the E-cadherin interaction network

Unlocking the complexity of cell adhesion Many biological processes depend on the ability of cells to stick to one another. The formation of multicellular organisms and precise embryonic development rely on this property, as does the maintenance of healthy tissue. Defects in the ability of cells to adhere to one another have been found in many diseases, such as cancer, Alzheimer’s disease and cardiovascular disease. In the case of cancer, ineffective cell adhesion allows tumour cells to detach and invade other tissues, thereby spreading cancer throughout the body. …

New molecules to burst malaria’s bubble

A new paper in PNAS is the third published recently by a group at the Australian National University (ANU). The group has collaborated with scientists from around the globe to uncover potential ammunition in the fight against malaria. Over 200 million people contract malaria each year, and the parasite that causes the disease has become resistant to most of the drugs currently available…

Substantial improvement in England, Wales cancer survival over 40 years overshadowed by low survival for brain, stomach, lung, oesophageal, and…

Led by the Cancer Research UK Cancer Survival Group at the London School of Hygiene & Tropical Medicine, London, UK, the researchers analysed survival trends for more than 7 million adults (aged 15 to 99 years) diagnosed with one of 21 common cancers in England and Wales between 1971 and 2011, and followed up to the end of 2012. The 21 cancers clearly divided into three groups with either high, moderate, or low survival…

Lung cancer risk model refines decisions to screen

Computed Tomography (CT) screening can identify lung tumors while they are still treatable, and the US National Lung Screening Trial (NLST) found that annual screening of high-risk smokers can reduce lung cancer mortality by 20%. The best way to identify those at high risk remains an important question. …

3-D mammography improves cancer detection in dense breasts — ScienceDaily

Breasts are considered dense if they have a lot of fibrous or glandular tissue but not much fatty tissue. Research has shown that dense breasts are more likely to develop cancer, a problem compounded by the fact that cancer in dense breasts can be difficult to detect on mammograms. Other imaging modalities like ultrasound and MRI are often used to help find cancers that can’t be seen on mammograms, but both modalities have higher rates of false-positive findings, which are suspicious findings that turn out not to be cancer. This higher false-positive rate often results in more tests and unnecessary biopsies, making MRI and ultrasound expensive to implement in high-volume screening programs, according to study lead author Per Skaane, M.D., Ph.D., from the Department of Radiology at Oslo University Hospital in Oslo, Norway. …

Prognostic role found for miR-21 expression in triple-negative breast cancer — ScienceDaily

TNBC accounts for 15% to 20% of breast cancer cases, and patients have shorter recurrence-free survival (RFS) and breast cancer-specific survival (CSS) relative to other major subgroups. It is likely that different subtypes of TNBCs exist, and the heterogeneity may be responsible for a wide variation in response to treatment. “Predictive biomarkers for therapeutic response prediction and novel therapeutic targets that address distinct biological features of TNBC subgroups are needed for these patients,” says Lorenzo F. Sempere, PhD, head of the Laboratory of microRNA Diagnostics and Therapeutics at Van Andel Research Institute in Grand Rapids, MI. …

Protein kinase R and dsRNAs, new regulators of mammalian cell division

This finding will provide important clues to understanding the process of tumor formation and the mechanism for suppressing cancer since the abnormal cell division marks the early events of cancer development. For the first time, the IBS research team has found that during mitosis, the cellular dsRNAs activate PKR, an enzyme previously known as a trigger of immune response during virus infection. Activated PKR then regulates protein synthesis and orchestrates mitotic processes…